Delivery Order SPE2DR25D1017-SPE2DR26F9BYC
- Not listed
- The Defense Logistics Agency awarded a $4,235.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Latuda 60 mg tablets, with an ultimate completion date of December 22, 2025. This non-set-aside contract was awarded competitively and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,787.95 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed price arrangement. The order was competitively awarded without set-aside designation and is scheduled for completion by May 7, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,295.43 to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $4,755.09 to AmerisourceBergen Drug Corp for the supply of Latuda 20 mg tablets (30-count packaging) on September 22, 2025, with completion expected by September 23, 2025. This firm fixed-price contract, with no set-aside designation, represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was made to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count packaging) under a firm fixed-price arrangement. The contract, valued at $7,553.45, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 29, 2025. AmerisourceBergen will perform fulfillment operations from its corporate office in Conshohocken, Pennsylvania, serving as a critical pharmaceutical...
- The Defense Logistics Agency awarded a $6,978.90 delivery order to AmerisourceBergen Drug Corp for Latuda 40 mg tablets (30-count units) on September 18, 2025, with a completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Latuda 40 mg tablets (quantity: 30 units) under a firm fixed price contract with a ceiling value of $10,349.66. The order is scheduled for completion by September 23, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a...
- The Defense Logistics Agency awarded a delivery order valued at $9,844.52 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count packages) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction under the company's broader pharmaceutical supply relationships with the federal government. The product will be delivered to AmerisourceBergen's...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BYCDelivery Order
The Defense Logistics Agency awarded a $45,234.27 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30-count bottles of Latuda 40 mg tablets. The contract, awarded on December 22, 2025, with performance completion by December 23, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical support vehicle valued through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's IDC serves as a primary sourcing mechanism for the Defense Health Agency and related military medical supply chains, providing critical access to brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The competitively awarded status of this delivery order and the company's extensive portfolio of federal contract awards demonstrate AmerisourceBergen's capability to meet federal medical procurement requirements. The DLA Troop Support Medical contract represents a strategic partnership supporting military readiness and healthcare operations worldwide through flexible and comprehensive pharmaceutical sourcing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45.2k | 12/21/25 |